Review Article Curre Res & Obes J Volume 4 Issue 4 - November 2017 Copyright © All rights are reserved by Alok Raghav DOI: 10.19080/CRDOJ.2017.04.555643

Neonatal Diabetes Mellitus: A Tale Still to Resolve

Alok Raghav1*, Jamal Ahmad2, Ashok Kumar Kaul1, Prerna Singh1, Himanshu Mamtani1, Syed Muntazir Andrabi1, Aman Nikhil1, Saba Noor2 and Brijesh Kumar Mishra3 1Department of Biological Sciences and Bioengineering, Indian Institute of Technology, India 2Rajiv Gandhi Centre for Diabetes & , JN Medical College, Aligarh Muslim University Aligarh, India 3Department of Endocrinology and Metabolism, GTB Hospital, University of Delhi, India Submission: October 10, 2017; Published: November 10, 2017 *Corresponding author: Alok Raghav, Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India, Email:

Abstract Transient diabetes mellitus and permanent diabetes mellitus in neonates are the primary forms of neonatal diabetes mellitus. TNDM

(IUGR).shows symptoms Among the of genetic diabetes makeover, mellitus initially in in the Kir6.2 first and week SUR1 of birth subunit and contribute undergo remission mostly in thein a development few months. ofIn this PNDM, form. The management secretion is successfullyaffected worsely includes and thereforethe application require of exogenousinsulin shots insulin subcutaneously from sources. to The subject to avoid of PNDM the hypoglycaemia is susceptible episodes. for intrauterine growth retardation

Introduction Clinical attributes of TNDM Neonatal diabetes mellitus (NDM) is a rarest devastating TNDM is a disorder of insulin generation from pancreatic beta high blood in combination with low insulin levels. On cells that resolves postnatally. It is presents in 50% to 60% cases metabolic disorder of newborns. It is characterized by significant of diabetes in neonates characterized by intrauterine growth into two prime groups namely, transient NDM (TNDM) and retardation (IUGR) [1]. High episodes of IUGR sets the crucial the basis of clinical recognition the NDM is further classified permanent NDM (PNDM), which differ from each other on the role of insulin in fetal development especially during the last basis of duration of insulin dependence. The transient form of NDM, which is of generic origin, is a developmental disorder insulin production and needs exogenous insulin supply. trimester of . TNDM is characterized by insufficient of insulin secretion from pancreatic beta cells that resolves Investigations comes negative for anti-islet antibodies and also postnatally mostly, but persist in around 50% to 60% neonatal for HLA class II haplotypes conferring mellitus cases. There are no recognized grounds that can predict a susceptibility [2]. Study has quoted defect in cell integrity in neonate with diabetes will have permanent or transient form. TNDM presentation [3]. Literature has also reported in exocrine Recently some molecular mechanisms are evolved that plays role in the understanding of PNDM and TNDM. cellular domain behind the TNDM pathogenesis id still unclear. pancreatic insufficiency in TNDM subjects [4]. Furthermore, the Most patients suffering from TNDM recovered from episodes Clinical characteristics within a year, leaving few with constant persistent glucose The symptoms of neonatal diabetes mellitus presents as , in rare cases episodes of and intolerance. In a French cohort study, the results showed that 8 years of age respond to permanent hyperglycemia requiring five out of seven TNDM presenting patients who were older than insulin therapy [5]. Moreover results of another cohort study on which may lead to coma within the first month of blood is primarily occurs in neonatal diabetes mellitus. Insulin life. Inadequate insulin production with significant less level of therapy from exogenous source is the hope in its management. TNDM subjects revealed that, diabetes mellitus (DM) episodes of age [6]. Conclusively, the “transient form” of the disease recurred in 11 subjects out of 18 patients older than 4 years

Curr Res Diabetes Obes J 4(4): CRDOJ.MS.ID.555643 (2017) 001 Current Research in Diabetes & Obesity Journal is associated with permanent failure of ß-cells with variable expression phases during the growth and development. partial duplication of long arm of the paternal 6 diabetic fathers [14]. Study also reported that few patients had is the prime factor that plays role in recurrent diabetes mellitus, [15]. Origin of TNDM occurs only, if the possibility of chromosome which is severely associated with . duplication arises from father. Paternal transfer of chromosomal abnormalities leads to hyperglycemia and susceptibility of Clinical attributes of PNDM diabetes in later stages of life. It is the less common form of diabetes compared to TNDM There are associated factors for the cause of PNDM molecular occurring in neonate. This form of diabetes occurs in neonatal mechanisms, primarily include in KCNJ11 period and does not undergo remission. In this form of diabetes encoding the protein Kir6.2 subunit of the ATPase there are no exactly precise clinical presentations that can complex, that involve in regulation of potassium ion across the predict, whether a neonate with symptoms of diabetes without membrane [16]. Dominant mutations occurring in ABCC8 also any dysmorphic features will occasionally develop permanent accounts for PNDM episodes [17]. or transient form of disease. It is reported that cases with the PNDM do not represents always IUGR, that is the characteristic Management and treatment of NDM feature of TNDM 6q phenotype [5,6]. The potassium channels plays important role in cellular Diagnosis of neonatal diabetes mellitus response to metabolic changes in insulin secretion. Approach of birth with hyperglycemia presentation. Rarely there are therapy proves to be promising approach in the treatment and Diagnosis of NDM occur within the first days or months of switching insulin injections to oral drug associated neural complications. The presentation time in NDM is also safe [18]. Insulin therapy is excellent choice therapy in is variable, and there is diagnostic problem in differentiation management of NDM with appreciable weight gain and growth between monogenic and autoimmune type 1 diabetes in the in neonates. In few circumstances, glucose and calorie intake early-onset children. In a previous study conducted on 111 deprivation has been instituted in neonates in the form of hyperglycemia to restrict insulin therapy approach. In neonates reported a highest frequency of protective HLA antigens and less with presentation of TNDM, subcutaneous ultralente insulin diabetic children who desire insulin within first year of life, it is frequent in children with diabetes onset before 180d compared approach is appreciable without the episodes of hypoglycaemia to those with more than 180d [7]. Another studies reported [19]. that incidences of diabetic cases prior to 6 months of age are Long-term risk for health of children with NDM monogenic in origin [8,9]. The data presently available strongly favours that episodes of diabetes diagnosed prior to 6 months of Infants with NDM, have permanent diabetes, others have age are probably monogenic in origin and thus required genetic remission of the former, that later recurre, leaving some screening. Hyperglycemia is commonly attributed by fasting patients with permanent remission. Moreover, diabetes mellitus plasma glucose 7.0mmol/L [10]. While NDM plays important role may recur after a long duration, one should may consider its in the differential diagnosis of neonatal hyperglycemia, it is also remission permanent, and also consider the neonatal diabetes as quite rarely occurring complications of neonates. High infusion a prediabetic state [20]. It is question always with the NDM that rates of glucose doesn’t effect the neonatal hyperglycemia in do the long-term outcomes in neonates indicate that NDM is to preterm and also in low-weight birth neonates, as prematurity be consider more than one disorder? NDM have few similarities and IUGR, both are concomitantly associated with immaturity with insulin-dependent diabetes as it happens in older children. of B-cells and also its mass respectively that results in insulin In this heredity plays a prime role along with HLA haplotypes [20]. It is concluded from the previous study that permanent and includes inotropes, glucocorticoids management, lipid infusions, long-term remissions of diabetes are very unusual in insulin- deficiency [11,12]. Other factors that cause complications caffeine and theophylline [13]. Another important fact is that dependent diabetes mellitus, that is quite frequent in NDM [20]. some surgical procedures, anaesthesia along with critical illness Conclusion also causes elevation in blood sugar levels, potentially secondary to stress episodes and concomitant elevated expression of Neonatal diabetes mellitus is a rare conditions presented in cortisol and epinephrine, less insulin release and disturbed neonates in two forms mainly TNDM and PNDM. However, it is glucose utilization [13]. NDM is also associated with secondary probably a matter of concern to understand the molecular and hyperglycemia caused due to amino acid metabolism [13]. genetic mechanism lies behind this worst complications. The Interestingly making differentiation between monogenic and understanding of NDM and its forms easily help in the proper autoimmune diabetes mellitus can be a potential diagnostic management in neonates. dilemma that imparts variable duration of presentation of NDM. References Molecular makeover of TNDM and PNDM 1. Von Muhlendahl KE, Herkenhoff H (1995) Long-term course of TNDM is commonly sporadic in nature, but in some cases paternal transmission has been reported in patients having non- 2. neonatalShield JP, diabetes. Gardner NRJ, Engl Wadsworth J Med 333(11): EJ, Whiteford 704-708. ML, James RS, et al.

How to cite this article: Alok R, Jamal A, Ashok K K, Prerna S, Himanshu M, et al. Neonatal Diabetes Mellitus: A Tale Still to Resolve. Curre Res Diabetes 002 & Obes J. 2017; 4(4): 555643. DOI: 10.19080/CRDOJ.2017.04.555643. Current Research in Diabetes & Obesity Journal

(1997) Aetiopathology and genetic basis of neonatal diabetes. Arch Dis 12. Ogilvy Stuart AL, Beardsall K (2010) Management of hyperglycaemia in

3. Child Fetal Neonatal Ed 76(1): F39-F42. 13. theBeardsall preterm K, .Vanhaesebrouck Arch Dis Child S, Ogilvy Fetal Neonatal Stuart AL, Ed Vanhole95(2): F126-F131. C, Palmer CR, et al. (2010) Prevalence and determinants of hyperglycemia in Ferguson AW, Milner RD (1970) Transient neonatal diabetes mellitus very low birth weight infants: cohort analyses of the NIRTURE study. J in sibs. Arch Dis Child 45(239): 80-83. Pediatr 157(5): 715-719. 4. Fosel S (1995) Transient and permanent neonatal diabetes. Eur J Von Muhlendahl KE, Herkenhoff H (1995) Long-term course of 5. PediatrMetz C, 154(12): Cave H, 944-948.Bertrand AM, Deffert C, Giroux BG, et al. (2002) Neonatal diabetes mellitus: chromosomal analysis in transient and 14. 15. neonatalCave H, diabetes.Polak M, N DrunatEngl J Med S, 333(11):Denamur 704-708. E, Czernichow P (2000) 6. permanentTemple IK, cases.Gardner The RJ, Journal Mackay of Pediatrics DJ, Barber 141(4): JC, Robinson 483-489. DO, et al. (2000) Transient neonatal diabetes: widening the understanding of Refinement of the 6q chromosomal region implicated in transient 16. neonatal diabetes. Diabetes 49(1): 108-113. Activating mutations in the gene encoding the ATP-sensitive 7. theIafusco etiopathogenesis D, Stazi MA, ofCotichini diabetes. R, Diabetes Cotellessa 49(8): M, Martinucci 1359-1366. ME, et al. potassium-channelGloyn AL, Pearson ER,subunit Antcliff Kir6.2 JF, Proksand permanent P, Bruining neonatal GJ, et al. diabetes. (2004)

(2002) Permanent diabetes mellitus in the first year of life. Diabetologia 17. NBabenko Engl J Med AP, 350(18):Polak M, 1838-1849.Cave H, Busiah K, Czernichow P, et al. (2006) 8. 45(6): 798 -804. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT (2006) 18. N Engl J Med 355(5): 456-466. diabetes diagnosed in the first 6 months of life, with the phenotype (2006) Switching from insulin to oral in patients with 9. determined by genotype. Diabetologia 49(6): 1190-1197. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, et al. Mutations in ATP-sensitive K channel cause transient neonatal diabetesFlanagan and SE, permanentPatch AM, Mackay diabetes DJ, in Edghill childhood EL, orGloyn adulthood. AL, et al. Diabetes (2007) 19. diabetesMitamura due R, Kimurato Kir6.2 H, mutations. Murakami N Y, Engl Nagaya J Med K, 355(5): Makita 467-477.Y, et al. (1996) 56(7): 1930-1937. Ultralente insulin treatment of transient neonatal diabetes mellitus. The Journal of Pediatrics 128(2): 268-270. 10. Standard of Medical Care in Diabetes (2017) American Diabetes 20. Von Mühlendah KE, Herkenhoff H (1995) Long-term course of neonatal

11. AssociationMeetze W, Bowsher (ADA) guidelines R, Compton 40(Suppl J, Moorehead 1): 1-142. H (1998) Hyperglycemia diabetes. N Engl J Med 333(11): 704-708. in extremely- low-birth-weight infants. Biol Neonate 74(3): 214-221.

This work is licensed under Creative Your next submission with Juniper Publishers Commons Attribution 4.0 Licens DOI: 10.19080/CRDOJ.2017.04.555643 will reach you the below assets • Quality Editorial service • Swift Peer Review • Reprints availability • E-prints Service • Manuscript Podcast for convenient understanding • Global attainment for your research • Manuscript accessibility in different formats ( Pdf, E-pub, Full Text, Audio) • Unceasing customer service

Track the below URL for one-step submission https://juniperpublishers.com/online-submission.php

How to cite this article: Alok R, Jamal A, Ashok K K, Prerna S, Himanshu M, et al. Neonatal Diabetes Mellitus: A Tale Still to Resolve. Curre Res Diabetes 003 & Obes J. 2017; 4(4): 555643. DOI: 10.19080/CRDOJ.2017.04.555643.